Posterior Tibial Nerve Stimulation As Treatment for the Overactive Bladder

Overview

Journal Arab J Urol

Date 2015 Nov 12

PMID 26558070

Citations 5

Authors

Hammouda Sherif

Osama Abdelwahab

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate the efficacy of posterior tibial nerve stimulation (PTNS) as a treatment for the overactive bladder (OAB) resistant to medical treatment.

Patients And Methods: The study included 60 patients, comprising 55 women (92%) and five men (8%) with a mean (SD) age of 41.4 (10.8) years, who presented to the Urology Department of Benha University Hospital from June 2010 to October 2012. All patients were assessed initially by taking a history, a physical examination, urine analysis, routine laboratory investigations, and a urodynamic evaluation in the form of flowmetry, cystometry, and a pressure-flow study in some cases. A voiding diary (daytime and night-time frequency, voiding volume, and leakage episodes) was completed by all patients, and all underwent 12 sessions of PTNS using a personal computer-based system, and were reassessed after the sixth session, at the end of the course, and at 3 and 6 months after the last session, using the same methods as in the baseline visit.

Results: There was a statistically significant improvement in all the variables assessed. No infection or failure of the PTNS mechanism was detected while using the technique, but there were rare instances of minor bleeding and a temporary painful feeling at the insertion site.

Conclusion: PTNS is safe, and gives statistically significant improvements in the patient's assessment of OAB symptoms.

Citing Articles

Transcutaneous Tibial Nerve Stimulation for Quality-of-Life Improvement and Sleep Deficiency in Women with Primary Dysmenorrhea: A Randomized Clinical Trial.

Correyero-Leon M, Calvo-Rodrigo J, Alvarado-Omenat J, Llamas-Ramos R, Llamas-Ramos I J Clin Med. 2024; 13(20).

PMID: 39458212 PMC: 11508406. DOI: 10.3390/jcm13206262.

Percutaneous Tibial Nerve Stimulation in the Treatment of Refractory Idiopathic Overactive Bladder Syndrome: A Retrospective Cohort Study.

Frey J, Vidal A, Krebs J, Christmann C J Clin Med. 2023; 12(21).

PMID: 37959248 PMC: 10648249. DOI: 10.3390/jcm12216783.

Transcutaneous Tibial Nerve Stimulation for Primary Dysmenorrhea: A Protocol for a Randomized Controlled Trial.

Correyero-Leon M, Llamas-Ramos R, Calvo-Rodrigo J, Alvarado-Omenat J, Llamas-Ramos I Healthcare (Basel). 2023; 11(11).

PMID: 37297773 PMC: 10252587. DOI: 10.3390/healthcare11111633.

CUA guideline on adult overactive bladder.

Corcos J, Przydacz M, Campeau L, Gray G, Hickling D, Honeine C Can Urol Assoc J. 2017; 11(5):E142-E173.

PMID: 28503229 PMC: 5426936. DOI: 10.5489/cuaj.4586.

Cholinergic Antagonists Combined with Electrical Stimulation or Bladder Training Treatments for Overactive Bladder in Female Adults: A Meta-Analysis of Randomized Controlled Trials.

Cao Y, Lv J, Zhao C, Li J, Leng J Clin Drug Investig. 2016; 36(10):801-8.

PMID: 27384416 DOI: 10.1007/s40261-016-0425-8.

References

Van Rey F, Heesakkers J . Applications of neurostimulation for urinary storage and voiding dysfunction in neurological patients. Urol Int. 2008; 81(4):373-8. DOI: 10.1159/000167831. View

Klingler H, Pycha A, Schmidbauer J, Marberger M . Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: a urodynamic-based study. Urology. 2000; 56(5):766-71. DOI: 10.1016/s0090-4295(00)00727-5. View

Abrams P, Wein A . Recent advances: urology. BMJ. 2000; 321(7273):1393-6. PMC: 1119114. DOI: 10.1136/bmj.321.7273.1393. View

Arrabal-Polo M, Palao-Yago F, Campon-Pacheco I, Martinez-Sanchez M, Zuluaga-Gomez A, Arrabal-Martin M . Clinical efficacy in the treatment of overactive bladder refractory to anticholinergics by posterior tibial nerve stimulation. Korean J Urol. 2012; 53(7):483-6. PMC: 3406195. DOI: 10.4111/kju.2012.53.7.483. View

Svihra J, Kurca E, Luptak J, Kliment J . Neuromodulative treatment of overactive bladder--noninvasive tibial nerve stimulation. Bratisl Lek Listy. 2003; 103(12):480-3. View

Vandoninck V, van Balken M, Agro E, Petta F, Micali F, Heesakkers J . Posterior tibial nerve stimulation in the treatment of idiopathic nonobstructive voiding dysfunction. Urology. 2003; 61(3):567-72. DOI: 10.1016/s0090-4295(02)02378-6. View

Fjorback M, van Rey F, van der Pal F, Rijkhoff N, Petersen T, Heesakkers J . Acute urodynamic effects of posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with MS. Eur Urol. 2006; 51(2):464-70. DOI: 10.1016/j.eururo.2006.07.024. View

Staskin D, Peters K, MacDiarmid S, Shore N, de Groat W . Percutaneous tibial nerve stimulation: a clinically and cost effective addition to the overactive bladder algorithm of care. Curr Urol Rep. 2012; 13(5):327-34. PMC: 3438389. DOI: 10.1007/s11934-012-0274-9. View

McGuire E, Zhang S, Horwinski E, LYTTON B . Treatment of motor and sensory detrusor instability by electrical stimulation. J Urol. 1983; 129(1):78-9. DOI: 10.1016/s0022-5347(17)51928-x. View

10.

Swinn M, Kitchen N, Goodwin R, Fowler C . Sacral neuromodulation for women with Fowler's syndrome. Eur Urol. 2000; 38(4):439-43. DOI: 10.1159/000020321. View

11.

Peters K, Carrico D, Perez-Marrero R, Khan A, Wooldridge L, Davis G . Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol. 2010; 183(4):1438-43. DOI: 10.1016/j.juro.2009.12.036. View

12.

Geirsson G, Wang Y, Lindstrom S, Fall M . Traditional acupuncture and electrical stimulation of the posterior tibial nerve. A trial in chronic interstitial cystitis. Scand J Urol Nephrol. 1993; 27(1):67-70. DOI: 10.3109/00365599309180416. View

13.

Bemelmans B, Mundy A, Craggs M . Neuromodulation by implant for treating lower urinary tract symptoms and dysfunction. Eur Urol. 1999; 36(2):81-91. DOI: 10.1159/000067976. View

14.

Levin P, Wu J, Kawasaki A, Weidner A, Amundsen C . The efficacy of posterior tibial nerve stimulation for the treatment of overactive bladder in women: a systematic review. Int Urogynecol J. 2012; 23(11):1591-7. DOI: 10.1007/s00192-012-1712-4. View

15.

Peters K, Carrico D, MacDiarmid S, Wooldridge L, Khan A, McCoy C . Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study. Neurourol Urodyn. 2012; 32(1):24-9. DOI: 10.1002/nau.22266. View

16.

MacDiarmid S, Peters K, Shobeiri S, Wooldridge L, Rovner E, Leong F . Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol. 2009; 183(1):234-40. DOI: 10.1016/j.juro.2009.08.160. View

17.

Govier F, Litwiller S, Nitti V, Kreder Jr K, Rosenblatt P . Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol. 2001; 165(4):1193-8. View

18.

Correia S, Dinis P, Rolo F, Lunet N . Prevalence, treatment and known risk factors of urinary incontinence and overactive bladder in the non-institutionalized Portuguese population. Int Urogynecol J Pelvic Floor Dysfunct. 2009; 20(12):1481-9. DOI: 10.1007/s00192-009-0975-x. View

19.

Janssen D, Farag F, Heesakkers J . Urgent-SQ implant in treatment of overactive bladder syndrome: 9-year follow-up study. Neurourol Urodyn. 2012; 32(5):472-5. DOI: 10.1002/nau.22322. View

20.

van der Pal F, van Balken M, Heesakkers J, Debruyne F, Bemelmans B . Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: is maintenance treatment necessary?. BJU Int. 2006; 97(3):547-50. DOI: 10.1111/j.1464-410X.2006.06055.x. View